[Public expenditure caused by the consumption of illicit drugs in Germany].
OBJECTIVE
A scientifically based overview of public expenditures related to illicit drugs was lacking for Germany. The aim of the present project is to carry out for the first time a comprehensive estimation of direct (labelled and non-labelled) expenditures of the government and the social insurance funds related to the use of illicit drugs in Germany for the year 2006.


METHODS
Depending on the respective financing bodies, different ways of data collection were required. Data on drug-related expenditure were searched in publically available budget documents and statistical reports; moreover written requests were sent to the relevant public authorities. Information on the expenditures of social insurance funds was collected through standardised questionnaires, which were sent to the Statutory Pension Insurance Scheme (Rentenversicherung Bund) and the 40 biggest statutory health insurance companies. The collected data were extrapolated for the total statutory health insurance.


RESULTS
All in all, on the government side an amount of 3.7-4.6 billion Euro spent on the task of tackling illicit drugs (i. e., for prevention, intervention and law enforcement measures) was identified. The expenditures of the pension funds related to illegal drug use amount to 171.7 million Euro. For the statutory health insurances a total expenditure of 1.4 billion Euro was estimated.


CONCLUSIONS
The aim of the project - a first estimation of the public expenditures concerning illicit drugs in Germany - has been achieved. Nevertheless, there remains some degree of uncertainty regarding the overall result because of the heterogeneous data quality. The approximation of the amount of public expenditures concerning illegal drug use still gives no information about adequate spending or actual benefits. However, it provides the indispensable basis for such an assessment and contributes to a more objective discussion.
Mostardt
S
S
Universität Duisburg-Essen, Lehrstuhl für Medizin-Management, Essen. sarah.mostardt@medman.uni-due.de
Flöter
S
S
Neumann
A
A
Wasem
J
J
Pfeiffer-Gerschel
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D003415:Crime / Q000191:economics* / Q000517:prevention & control; D005260:Female; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D013287:Illicit Drugs / Q000191:economics*; D035846:Law Enforcement; D008297:Male; D008875:Middle Aged; D018803:Models, Economic; D009313:National Health Programs / Q000191:economics* / Q000706:statistics & numerical data; D010415:Pensions / Q000706:statistics & numerical data; D011634:Public Health / Q000191:economics*; D019966:Substance-Related Disorders / Q000191:economics* / Q000453:epidemiology* / Q000517:prevention & control; D055815:Young Adult
D013287:Illicit Drugs